Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Wood

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
Cost Effectiveness and Resource Allocation : C/E|May 9, 2026
An economic evaluation of the MultICath randomised controlled trial, comparing combined use of reusable and single-use intermittent catheters to single-use catheters onlySara McCloskey, Tracey H Sach, Margaret Macaulay, et al.
BMJ Open|December 22, 2018
Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol studyJohn P Bourke, Gillian Watson, Francesco Muntoni, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Thorax|August 7, 2017
Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trialStephen E Wright, Kirsty Thomas, Gillian Watson, et al.
Diabetes Care|April 18, 2018
Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical TrialStuart A Little, Jane Speight, Lalantha Leelarathna, et al.
Diabetes Care|November 22, 2014
Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Gut|July 15, 2014
Exercise and associated dietary extremes impact on gut microbial diversitySiobhan F Clarke, Eileen F Murphy, Orla O'Sullivan, et al.
Diabetes Care|May 24, 2014
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
Cost Effectiveness and Resource Allocation : C/E|May 9, 2026
An economic evaluation of the MultICath randomised controlled trial, comparing combined use of reusable and single-use intermittent catheters to single-use catheters onlySara McCloskey, Tracey H Sach, Margaret Macaulay, et al.
BMJ Open|December 22, 2018
Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol studyJohn P Bourke, Gillian Watson, Francesco Muntoni, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Thorax|August 7, 2017
Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trialStephen E Wright, Kirsty Thomas, Gillian Watson, et al.
Diabetes Care|April 18, 2018
Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical TrialStuart A Little, Jane Speight, Lalantha Leelarathna, et al.
Diabetes Care|November 22, 2014
Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Gut|July 15, 2014
Exercise and associated dietary extremes impact on gut microbial diversitySiobhan F Clarke, Eileen F Murphy, Orla O'Sullivan, et al.
Diabetes Care|May 24, 2014
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Pageof 4